These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20585032)

  • 1. Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice.
    Robles-Carrillo L; Meyer T; Hatfield M; Desai H; Dávila M; Langer F; Amaya M; Garber E; Francis JL; Hsu YM; Amirkhosravi A
    J Immunol; 2010 Aug; 185(3):1577-83. PubMed ID: 20585032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model.
    McKenzie SE; Taylor SM; Malladi P; Yuhan H; Cassel DL; Chien P; Schwartz E; Schreiber AD; Surrey S; Reilly MP
    J Immunol; 1999 Apr; 162(7):4311-8. PubMed ID: 10201963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes.
    Amirkhosravi A; Boulaftali Y; Robles-Carrillo L; Meyer T; McKenzie SE; Francis JL; Bergmeier W
    J Thromb Haemost; 2014 Dec; 12(12):2113-9. PubMed ID: 25287077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
    Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized mouse models of FcR clearance in immune platelet disorders.
    McKenzie SE
    Blood Rev; 2002 Mar; 16(1):3-5. PubMed ID: 11913983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes.
    Worth RG; Chien CD; Chien P; Reilly MP; McKenzie SE; Schreiber AD
    Exp Hematol; 2006 Nov; 34(11):1490-5. PubMed ID: 17046568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.
    Meyer T; Robles-Carrillo L; Robson T; Langer F; Desai H; Davila M; Amaya M; Francis JL; Amirkhosravi A
    J Thromb Haemost; 2009 Jan; 7(1):171-81. PubMed ID: 18983497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.
    Melki I; Allaeys I; Tessandier N; Mailhot B; Cloutier N; Campbell RA; Rowley JW; Salem D; Zufferey A; Laroche A; Lévesque T; Patey N; Rauch J; Lood C; Droit A; McKenzie SE; Machlus KR; Rondina MT; Lacroix S; Fortin PR; Boilard E
    Blood; 2020 Dec; 136(25):2933-2945. PubMed ID: 33331924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD40 in CD40L- and antibody-mediated platelet activation.
    Langer F; Ingersoll SB; Amirkhosravi A; Meyer T; Siddiqui FA; Ahmad S; Walker JM; Amaya M; Desai H; Francis JL
    Thromb Haemost; 2005 Jun; 93(6):1137-46. PubMed ID: 15968400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice.
    van Royen-Kerkhof A; Sanders EA; Walraven V; Voorhorst-Ogink M; Saeland E; Teeling JL; Gerritsen A; van Dijk MA; Kuis W; Rijkers GT; Vitale L; Keler T; McKenzie SE; Leusen JH; van de Winkel JG
    Br J Haematol; 2005 Jul; 130(1):130-7. PubMed ID: 15982355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis signal-regulating kinase 1 regulates immune-mediated thrombocytopenia, thrombosis, and systemic shock.
    Patel P; Shaik NF; Zhou Y; Golla K; McKenzie SE; Naik UP
    J Thromb Haemost; 2020 Nov; 18(11):3013-3028. PubMed ID: 32767736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
    Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Duffau P; Seneschal J; Nicco C; Richez C; Lazaro E; Douchet I; Bordes C; Viallard JF; Goulvestre C; Pellegrin JL; Weil B; Moreau JF; Batteux F; Blanco P
    Sci Transl Med; 2010 Sep; 2(47):47ra63. PubMed ID: 20811042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
    Arman M; Krauel K
    J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases.
    Xie JH; Yamniuk AP; Borowski V; Kuhn R; Susulic V; Rex-Rabe S; Yang X; Zhou X; Zhang Y; Gillooly K; Brosius R; Ravishankar R; Waggie K; Mink K; Price L; Rehfuss R; Tamura J; An Y; Cheng L; Abramczyk B; Ignatovich O; Drew P; Grant S; Bryson JW; Suchard S; Salter-Cid L; Nadler S; Suri A
    J Immunol; 2014 May; 192(9):4083-92. PubMed ID: 24670803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.